Konferenzen zum Thema Medizintechnik in Großbritannien

Wählen Sie ein Land aus
1
Molecular Hiving™ Technology — Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology
26. Nov 2020 • Online Webinar, Großbritannien
Veranstalter:
SMi Group
Zusammenfassung:
Bachem and Jitsubo CO., Ltd. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s Molecular Hiving™ Technology. Under the License agreement, Jitsubo will develop selected manufacturing processes using their Molecular Hiving™ Technology and transfer these processes to Bachem. Bachem will further optimize, scale up and produce for commercial applications. Molecular Hiving™ is a tag-assisted liquid-phase peptide synthesis technology developed by Professor Kazuhiro Chiba at Tokyo University of Technology and Agriculture. This technology uses a hydrophobic tag, which is applied in the same way as the resin for solid-phase peptide synthesis (SPPS) processes. The same standard Fmoc amino acid derivatives as for SPPS are applied for assembling the peptide chain. However, all couplings and cleavages of the Fmoc protecting group are performed in solution allowing for fast reactions and direct in-process controls, e.g. by HPLC. Excess reagents as well as coupling and cleavage related by-products are solely removed by aqueous extractions. Therefore, intermediate isolation of the tag-bound peptide and excessive washing steps are not required for Molecular Hiving™ Technology. In this webinar, the speaker will guide you through the individual steps for synthesis of peptides applying Molecular Hiving™ Technology. You will learn about the scalability and the substantial advantages of this technology regarding efficiency and towards greener manufacturing, as solvent consumption and material requirements are significantly reduced compared to conventional SPPS processes. Molecular Hiving™ also allows the synthesis of peptides without the use of solvents and reagents which are carcinogenic, mutagenic, or toxic to reproduction (CMR substances). This makes peptide products manufactured by this technology highly attractive for the pharmaceutical and cosmetics industry.
Kontakt:
Tel.: [02078276000];     Email: ssapal@smi-online.co.uk
Themen:
Drug Development, Peptide Synthesis, Molecule, Drug Discovery, Peptides, RNai,
Eintrags-ID:
1383345
Verwandte Fachgebiete:
2
Pharma Micro UK — SMi's 10th Annual Pharmaceutical Microbiology UK Conference
18. Jan 2021 - 19. Jan 2021 • London, Großbritannien
Veranstalter:
SMi Group
Zusammenfassung:
SMi’s flagship microbiology conference is celebrating its 10 year anniversary. The conference taking place on 18 and 19 January 2021 in London, UK will bring together industry experts to explore agile contamination control strategy’s that tackle the most pressing challenges and push innovation in the world of pharmaceutical microbiology. The two-day event will address Contamination Control Strategies, Effective Environmental Monitoring, and the newest schools of thought in personnel operation. Leaders in regulation and compliance will provide expert consultant’s viewpoints on how to implement and interpret the regulation. Also Annex 1 will be assessed and prepared for. All of this is to be presented with current case studies.
Kontakt:
Tel.: [02078276000];     Email: ssapal@smi-online.co.uk
Themen:
Pharmaceutical, microbiology, contamination, microbial, biofilms, sterility, quality assurance, mycoplasma, data integrity, microbiome, Endotoxins
Eintrags-ID:
1377524
3
3D Cell Culture — SMi’s 5th Annual 3D Cell Culture Conference
10. Feb 2021 - 11. Feb 2021 • Online, Großbritannien
Veranstalter:
SMi Group
Zusammenfassung:
3D Cell Culture is gaining momentum in the pharmaceutical industry, with the global 3D Cell Culture market predicted to surpass a value of $3.2 Billion by 2027. Researchers globally are realising the potential of in vitro applications for drug discovery, predictivity and validation, safety, and toxicity. SMi’s 5th Annual 3D Cell Culture Conference will be covering the application of 3D cell culture to drug development, toxicity testing, and safety assurance. In addition, the conference will look into the newest breakthroughs in Organ Chip technology, 3D Multicellular scaffolding, Microphysiological Systems, and 3D Bioprinting. In recent years technological advances have made these technologies viable and accessible in scientific application.
Kontakt:
Tel.: [02078276000];     Email: ssapal@smi-online.co.uk
Themen:
Organ-on-chips, microfluidics, cell culture, 3D cell culture, 3D bioprinting, bioprinting, organoid, extracellular matrix, ECM, tissue engineering, physiochemical factors, cell-based assay, cytotoxicity, cell metabolic pathways, cancer research, molecular diagnostics, cell and gene therapy, microphysiological, co-culture systems complex in-vitro models, high throughput screening, 3D imaging, drug screening, extracellular matrix scaffolds, 3D drug development, regenerative therapies
Eintrags-ID:
1383368
4
Radiotherapy Physics Course — Accelerator Design, Radiobiology, Quality Assurance, Brachytherapy and Radiotherapy Imaging
02. Mär 2021 - 06. Mär 2021 • London, Großbritannien
Veranstalter:
The Institute of Cancer Research (ICR)
Zusammenfassung:
This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy. It is aimed primarily at recently qualified radiotherapy physicists, but should also be invaluable to post-graduate students, researchers, clinical oncologists, engineers, radiographers, manufacturers’ representatives and in fact, anyone needing to deepen or update their understanding of this rapidly evolving field.
Eintrags-ID:
1356452


Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 09. Oktober 2020